The Medical University of Vienna has discovered “a specially synthesized plant peptide (cyclotide),” where, “there is no further progression of the usual clinical signs of multiple sclerosis.” (Science Daily) The European study used an animal model to demonstrate the effects of cyclotide on MS. To add to the good news, the administration of the drug is oral. It is believed the development of a drug with this plant could slow down or possibly even stop the progression of MS and improve symptoms. Other auto immune diseases may also benefit from the potential drug. Human studies could begin as early as the end of 2018.

Learn more at: https://www.sciencedaily.com/releases/2016/03/160317233550.htm. Image from canaranews.com.